S_mmary Epidermal growth factor receptor (EGFR) overexpression has been associated frequently with squamous cell carcinomas (SCC) and SCC cell lines. In most cases the level of EGFR on the tumours from which the cell lines were derived has not been determined, nor 
The EGFR is frequently, but not necessarily, overexpressed on SCC-derived cell lines (Wrann & Fox, 1979; Merlino et al., Cowley et al., 1984 Cowley et al., , 1986 Ozanne et al., 1986a; Prime et al., 1994) and tumours (Hendler & Ozanne, 1984; Gullick et al., 1986; Ozanne et al., 1986b; Derynck et al., 1987; Hendler et al., 1989; Ishitoya et al., 1989; Weichselbaum et al., 1989; Gullick, 1991; Gorgolis et al., 1992) . Its gene, c-erbB (Downward et al., 1984) , is located on chromosome 7pl2-14 and spans at least 10kb (Haley et al., 1987) . It encodes two mRNAs of 10 and 5 kb . The EGFR is a phosphoglycoprotein of 170 kDa (Prigent & Lemoine, 1992) . The extracellular domain binds ligand, which activates the intracellular domain protein tyrosine kinase. The ligands for the EGFR include epidermal growth factor (EGF) (Savage et al., 1972) , transforming growth factor alpha (TGF-x) (DeLarco & Todaro, 1978) , heparin-binding epidermal growth factor (HBEGF) (Higashiyama et al., 1991) and amphiregulin (AR) (Shoyab et al., 1989) . Both non-malignant keratinocytes and squamous cell carcinomas can produce EGF and TGF-a (Coffey et al., 1987; Derynck et al., 1987; Yoshida et al., 1990) and HBEGF (Cook et al., 1991) and thereby may constitute an autocrine system (Sporn & Todaro, 1985) . The first indication that overexpression might be important to tumour growth was provided by experiments with the vulval epidermoid carcinoma-derived cell line, A431, which has 2 x 106 EGFRs per cell. Variants were selected which had fewer EGFRs. These variants were less tumorigenic than the parental A431 cells (Santon et al., 1986) . Overexpression of EGFR by SCC cell lines might help them respond to low amounts of EGF or TGF-a, while inhibition of ligand binding to the EGFR by EGFR-specific monoclonal antibodies seems to block the growth of SCC cell lines in tissue culture and xenografts, which highlights the importance of the EGFR to the growth of SCC (Masui et al., 1984; Modjtahedi et al., 1993a, b) . Owing to its reported overexpression, the EGFR has been suggested to be a potential target for diagnosis (Soo et al., 1987; Divgi et al., 1991) or directed therapy of SCC (Harris, 1990; Ennis et al., 1991) . Although several studies have indicated that the EGFR is overexpressed on human SCC, quantitation of the overexpression relies heavily on the study of SCC-derived cell lines in which the frequency of significant overexpression is very high (Cowley et al., , 1986 . Most studies have relied upon cell lines which have been isolated under culture conditions unfavourable for the growth of normal keratinocytes (Easty et al., 1981) . Thus, they may have selected for tumours which express very high levels of EGFR in vivo; otherwise only a minority of the tumour cells that overexpress the EGFR would be selected for growth in culture. A recent study which established cell lines from oral cavity tumours found that only one out of eight cell lines overexpressed the EGFR (Prime et al., 1994) . In the present study we have analysed EGFR expression on a series of cell lines derived from SCCHN under culture conditions favourable for the growth of normal keratinocytes (Rheinwald & Beckett, 1981) . We have also determined EGFR levels on cryosections of the original tumours and on xenografts of some of the cell lines. Mary's Hospital Medical SchooL London, UK). Cells were maintained in keratinocyte SFM (Gibco), supplemented with bovine pituitary extract (Clonetics), EGF (1Ongmlm') and antibiotics. Human epidermal keratinocytes (HEKs) were maintained in complete KGM (Clonetics).
Materials and methods

Cell
BICR squamous cell carcinoma lines listed in Table I (K. Edington et al., manuscript in preparation) were grown on lethally irradiated NIH3T3 feeder cells (Rheinwald & Green, 1975) diluted to a specific activity of 0.05 iLCi ng-' with unlabelled EGF (mouse, tissue culture grade, Sigma). The assay was performed as described previously (Cowley et al., 1986) . Briefly, cells were plated at a density of 1 x I0O cells per well in 24-well tissue culture plates 24h before the assay. The wells were washed three times with phosphate-buffered saline (PBS), and incubated with labelled EGF in the presence or absence of a 100-fold excess of unlabeled competitor in 0.5 ml of PBS with 1% BSA at room temperature for 1 h. The range of competitor was 11 points between 1.0ng and 1 pg. Cells were then washed five times with ice-cold PBS/5% BSA, solubilised in 1 ml of 1 N sodium hydroxide and the amount of radioactivity determined in a gamma counter. Counts were corrected for background and cell number and data were analysed using th LIGAND program.
Binding of EGFRI and EGF to placental membrane preparations EGF and EGFR1 were radioiodinated using iodogen to specific activities of 40 and 250 jICi g-' respetively. Human syncytiotrophoblast plasma membranes were prepared by cold isotonic saline extraction (Smith et al., 1974 (Reeves et al., 1993) . EGFRI was detected using biotinylated rabbit anti-mouse antibody, and non-immune mouse IgG2b was used as a control for non-specific antibody binding. (Reeves et al., 1993) .
Quantitation of EGFR on cryosections of twnours Cryosections were made from frozen tumour or xenograft specimens (K. Edington, manuscript in preparation). The sections were fixed in 50% acetone-PBS. Two sections from each specimen were incubated with 200,000 c.p.m. of
['"I]EGFRI (specific activity of 2.5 x I0 c.p.m. mg-EGFR1) for 3 h at 24'C in a volume of 100 tl of 50% calf serum-PBS. Another section was treated similarly but a 200-fold excess of unlabelled EGFR1 was included in the 100 1. The sections were washed four times with 10% calf serum-PBS, rinsed with water, air dried and placed in an X-ray cassette and exposed to film for 16 h. The sections were dipped in photographic emulsion (NTB-2 Kodak) and exposed for sufficient time to generate between 100 and 400 grains per 100 Im2. The time of exposure was estimated from the density of the autoradiograph. Based on densitometric scanning of the A431 cell pellet sections, the emulsions of A431 require 4 h exposure to give an acceptable grain density. EJ cell pellets or normal sklin require 48 h. The silver grains are counted per high-power field (HPF) which equals 6.67 x 10-mm2 with ten fields per slide using a Joyce-Loebel Nikon Magiscan computer. Using this protocol, approximately equal numbers of grains were counted per sample and expressed as the number of grains 100 zm-2 h-' exposure after subtracting the background binding.
Resuls EGFR levels on the SCCHN cell lines
Ligand-binding studies have been used to determine the number of EGFRs on many different cell types. Previously it has been detemined that normal keratinocytes grown in tissue culture express 2.7 x i0 EGFRs per cell (Cowley et al., , 1986 or 5.5 x 106 EGFRs per cell if isolated from gingival mucosa (Prime et al., 1994) , while most SCC-derived cell lines express around 106 EGFRs per cell. (Cowley et al., , 1986 . We performed ['25I]EGF binding studies to determine the number of EGFRs per cell on ten SCCHN, two erythroplakia-derived cell lines, HPV16 E7, E6 immortalised foreskin keratinocytes (TFK104) and HEKs (Table I) .
Eight of the cell lines express from 9 x 106 to 1.8 x 10' EGFRs per cell, as do most other SCC-derived cell lines. One of the tumour-derived cell lines, BICR19, and one of the erythroplakia-derived cell lines, BICRE4, showed no increase in EGFR expression compared with HEK, whik BICR18 and TFK104 showed a 2-fold increase in EGFRs compared with HEKs. In BICR18, BICR19, BICRE4 and BICRE5 the levels of EGFR were similar to those found in a recent study (Primw et al., 1994) . Thus, it is not esssential for all SCCHN- derived cell lines to overexpress EGFR, nor is HPV16 E7 and E6 expression sufficient to cause more than a 2-fold increase in EGFR expression. (Waterfield et al., 1982) , to cryosections of tumour biopsy specimens (Gusterson et al., 1984; Hendler & Ozanne, 1984; Ozanne et al., 1986; Hendier et al., 1989) . To demonstrate the specificity of EGFR1, we observed the binding of EGF (Figure la and b) and EGFR1
( Figure Ic and d) Binding assays were performed on placental membrane preparations. The data represent the average of two independent analyses as described in the Materials and methods section. Analysis of cryosections of the tumours (where available) from which the BICR cell lines listed in Table I (Table V) . The increase in EGFR expression in these tumours was higher than in normal skin, but the difference was not as great as that between the cell lines and HEKs (Table I ). The other tumours from which cell lines were derived which have significant increases in EGFR expression did not have a significant increase in EGFR compared with normal skin. In fact one of them, BICR22, displayed a decrease in the actual tumour, while the cell line had a 5-fold increase. The cell lines which displayed slightly elevated or HEK levels of EGFR, BICR18 and BICRl9 respectively, were derived from tumours with slightly elevated or skin levels of EGFR respectively. This indicates that the EGFRl-binding assay does not give artificially low levels of EGFR on the tumour sections.
The data above suggested that the increased expression of EGFR observed on the BICR lines is a property of a subset of tumour cells that grow in tissue culture and does not reflect the state of expression in the original tumour. An alternative explanation is that the potential to overexpress the EGFR is suppressed in the tumours. To evaluate the alternative explanation, we analysed xenograft tumours of some of the cell lines isolated from nude mice. BICR6, BICRIO and BICR22 expressed essentially the same level of EGFR as they did in the tumour biopsy assays (Table V) . Binding of EGFR1 to the xenografts for BICR16 and BICRl9 was almost non-existent, which may reflect the highly differentiated state of these xenografts (data not shown).
D6cssion
Using EGF ligand-binding assays we have demonstrated that 80% of a series of cell lines derived from SCCHN had a significant increase in the level of expression of EGFR, consistent with most previously reported studies (Cowley et al., , 1986 Ozanne et al., 1986; Hendler et al., 1989; Weichselbaum et al., 1989) . In two of the cell lines, however, EGFR expression was similar to that normally seen in HEKs maintained in tissue culture. Two cell strains derived from erythroplakias did not have elevated levels of EGFR. This suggests that increased EGFR expression is not necessarily associated with premalignant lesions as both lesions progressed to SCC within a year (K. Edington et al., manuscript in preparation). Furthermore, both BICRE4 and BICRE5 are defective for terminal differentiation when placed in suspension culture, which is consistent with their representing premalignant keratinocytes. Recently it has been suggested that expression of the EGFR and TGF-x expression is increased in dysplastic lesions adjacent to SCCHN (Grandis & Tweardy, 1993 ['25IlEGFRI in the presence of a 100-fold excess of unlabelled EGFRI. A431 sections were exposed for 4 h. All others were exposed for 48 h, I of the tumour-derived cell lines show a 5-fold increase in EGFR expression in tissue culture compared with in vivo. A similar conclusion can be drawn from the two erythroplakiaderived cell strains, BICRE4 and BICRE5, which display at most a 2-fold higher level of EGFR expression than HEKs.
EGFR may have a dual role in tumorigenesis: to increase the growth of the cells as a mitogen and to prevent terminal differentiation (Rhienwald & Green. 1977) . Studies with antagonistic anti-EGFR monoclonal antibodies have demonstrated that SCC cell lines require EGFR for growth (Masui et al., 1984; Modjtahedi et al., 1993b (Burns et al., 1993) Ozanne, unpublished data) . Perhaps the continuous signal from the EGFR and increased expression of CCND1 obviate the need for pRB mutations. Alternatively, pRB105 may not be important in the regulation of the cell cycle of keratinocytes and therefore its inactivation is not required.
Although the weight of the published studies indicates that EGFR overexpression is common in squamous cell carcinomas both in vivo and in vitro, it appears that the level of expression cannot be predicted from cell lines or tumours. It may be that the potential to overexpress is more common than the actual overexpression. Although recent data suggest that EGFRs are necessary for the growth of SCC derived cell lines (Modjtahedi et al., 1993b) 
